Methylnitronitrosoguanidine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Methylnitronitrosoguanidine[1]
Structural formula of methylnitronitrosoguanidine
Space-filling model of the methylnitronitrosoguanidine molecule
Names
Preferred IUPAC name
N-Methyl-N'-nitro-N-nitrosoguanidine
Other names
1-Methyl-3-nitro-1-nitrosoguanidine
N-Methyl-N-nitroso-N′-nitroguanidine
Identifiers
3D model (JSmol)
Abbreviations MNNG
ChemSpider
ECHA InfoCard 100.000.664
KEGG
Properties
C2H5N5O3
Molar mass 147.09 g/mol
Appearance Yellow crystals
Melting point 118 °C (244 °F; 391 K) (decomposes)
reacts violently, slowly hydrolysed
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
No verify (what is YesYNo ?)
Infobox references

Methylnitronitrosoguanidine (MNNG or MNG) is a biochemical tool used experimentally as a carcinogen and mutagen.[1] It acts by adding alkyl groups to the O6 of guanine and O4 of thymine, which can lead to transition mutations between GC and AT. These changes do not cause a heavy distortion in the double helix of DNA and thus are hard to detect by the DNA mismatch repair system.

One of the earliest uses of Methylnitronitrosoguanidine was in 1985. A group of scientists tested whether or not the chemical composition of Methylnitronitrosoguanidine would directly affect the growth of tumors and cancer cells in rats.

In the experiment, the cancer cells from a japanese cancer patient was injected in the 8 rats. The biochemical tool and showed a decline of cancer cells in a few of the rats bodies.

In organic chemistry, MNNG is used as a source of diazomethane when reacted with aqueous potassium hydroxide.[2]

MNNG is a probable human carcinogen listed as an IARC Group 2A carcinogen.[3]

References[edit]

  1. ^ a b Merck Index, 11th Edition, 6017.
  2. ^ Aldrichimica Acta. 16 (3). 1983.  Missing or empty |title= (help)
  3. ^ N-METHYL-N'-NITRO-N-NITROSOGUANIDINE (MNNG), International Agency for Research on Cancer